BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20133283)

  • 1. Half the dosage, similar efficacy, less bleeding: the new tissue plasminogen activator regimen for pulmonary embolism?
    Davidson BL
    Chest; 2010 Feb; 137(2):245-7. PubMed ID: 20133283
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose tissue plasminogen activator in pulmonary embolism: benefit remains unclear.
    Saito S; Altaqi B; Simeone F
    Chest; 2011 Feb; 139(2):479-480. PubMed ID: 21285071
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic thrombolysis in pulmonary embolism - another paradigm falling?
    Freisinger E; Reinecke H
    Vasa; 2015 Mar; 44(2):156. PubMed ID: 25698395
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism.
    Islam MS
    Adv Exp Med Biol; 2017; 906():67-74. PubMed ID: 27628004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To bleed or not to bleed..
    Pena TA
    Chest; 2010 Dec; 138(6):1520; author reply 1520-1. PubMed ID: 21138890
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.
    Wang C; Zhai Z; Yang Y; Wu Q; Cheng Z; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH;
    Chest; 2010 Feb; 137(2):254-62. PubMed ID: 19741062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Half-Dose Versus Full-Dose Alteplase for Treatment of Pulmonary Embolism.
    Kiser TH; Burnham EL; Clark B; Ho PM; Allen RR; Moss M; Vandivier RW
    Crit Care Med; 2018 Oct; 46(10):1617-1625. PubMed ID: 29979222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of massive pulmonary embolism with low-dose tissue plasminogen activator after meniscus surgery.
    Zencirkiran Agus H; Uygur B; Guler A; Demirci G; Kalkan AK; Yildiz M
    Blood Coagul Fibrinolysis; 2018 Sep; 29(6):559-561. PubMed ID: 29985194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massive pulmonary embolism in a young boy with T-cell leukaemia. Successful thrombolytic therapy by recombinant tissue plasminogen activator (rtPA).
    Beck O; Martin C; Alt F; Wingerter A; Staatz G; Schinzel H; Faber J
    Hamostaseologie; 2014; 34(3):233-6. PubMed ID: 24975773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolytic treatment of acute pulmonary embolism.
    Charbonnier B; Meyer G; Stern M; Sors H; Brochier ML
    Herz; 1989 Jun; 14(3):157-71. PubMed ID: 2500388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Importance of Low-Dose Tissue Plasminogen Activator Policy for Treating Intraoperative Pulmonary Thromboembolism During Liver Transplantation.
    Mandell D; Planinsic R; Melean F; Hughes C; Tevar AD; Humar A; Cassidy BJ; Simmons R; Dewolf A; Sakai T
    Semin Cardiothorac Vasc Anesth; 2018 Dec; 22(4):376-382. PubMed ID: 29488445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safe dose rTPA for massive pulmonary embolism associated with high bleeding risk: a case report and review of the literature].
    Mele M; Mele A; La Torre PP; Cannone M
    G Ital Cardiol (Rome); 2014 Apr; 15(4):240-3. PubMed ID: 24873813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenecteplase can be given to patients with intermediate-risk pulmonary embolism--but should it?
    Lankeit M; Konstantinides S
    Thromb Res; 2010 Dec; 126(6):e407-8. PubMed ID: 19896704
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombolytic therapy in pulmonary embolism. Indications and therapeutic strategies].
    Niedermeyer J; Meissner E; Fabel H
    Z Gesamte Inn Med; 1993; 48(6-7):332-43. PubMed ID: 8333230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early lytic treatment of massive pulmonary embolism.
    Cardiovasc J S Afr; 2002; 13(4):218-9. PubMed ID: 12402933
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultrasound-Assisted Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism.
    Mohan PP; Manov JJ; Contreras F; Langston ME; Doshi MH; Narayanan G
    Vasc Endovascular Surg; 2018 Apr; 52(3):195-201. PubMed ID: 29436310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Images in cardiovascular medicine. Regression of thrombus and electrocardiographic changes with thrombolytic therapy in acute massive pulmonary embolism.
    Bozcali E; Tutpinar Y
    Circulation; 2008 Nov; 118(21):2207-8. PubMed ID: 19015415
    [No Abstract]   [Full Text] [Related]  

  • 18. [The PEITHO study].
    Alunni G; Coen D
    G Ital Cardiol (Rome); 2014 Nov; 15(11):591-5. PubMed ID: 25424135
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pulmonary embolism: could thrombolysis be extended to patients with intermediate-risk pulmonary embolism?].
    Bouzerda A; Serghini I; Kharass AE
    Pan Afr Med J; 2017; 26():238. PubMed ID: 28690752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary saddle thrombus.
    Jandial A; Mishra K; Kumar S; Malhotra P
    QJM; 2018 Dec; 111(12):907-908. PubMed ID: 29945219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.